Khalid B. Selim

1.1k total citations
42 papers, 876 citations indexed

About

Khalid B. Selim is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Khalid B. Selim has authored 42 papers receiving a total of 876 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Organic Chemistry, 19 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Khalid B. Selim's work include Synthesis and biological activity (14 papers), Synthetic Organic Chemistry Methods (9 papers) and Quinazolinone synthesis and applications (8 papers). Khalid B. Selim is often cited by papers focused on Synthesis and biological activity (14 papers), Synthetic Organic Chemistry Methods (9 papers) and Quinazolinone synthesis and applications (8 papers). Khalid B. Selim collaborates with scholars based in Egypt, Japan and France. Khalid B. Selim's co-authors include Kiyoshi Tomioka, Ken‐ichi Yamada, Yasumasa Matsumoto, Magda A.‐A. El‐Sayed, Amany Mostafa, Laila Abou‐Zeid, Yasutomo Yamamoto, Hassan M. Eisa, Takahiro Soeta and Masami Kuriyama and has published in prestigious journals such as Angewandte Chemie International Edition, Chemical Communications and The Journal of Organic Chemistry.

In The Last Decade

Khalid B. Selim

40 papers receiving 866 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khalid B. Selim Egypt 17 773 192 159 60 39 42 876
Bodo Scheiper Germany 12 609 0.8× 242 1.3× 100 0.6× 88 1.5× 13 0.3× 13 863
Sravani Sana India 14 562 0.7× 255 1.3× 37 0.2× 57 0.9× 16 0.4× 18 668
You‐Cai Xiao China 19 977 1.3× 311 1.6× 210 1.3× 105 1.8× 7 0.2× 38 1.2k
Craig A. Zificsak United States 18 1.1k 1.4× 202 1.1× 74 0.5× 40 0.7× 10 0.3× 27 1.2k
Daniel T. Cohen United States 16 1.2k 1.5× 298 1.6× 185 1.2× 55 0.9× 15 0.4× 20 1.4k
Rajesh Gontla Germany 12 683 0.9× 169 0.9× 193 1.2× 31 0.5× 14 0.4× 14 803
Akash P. Sakla India 13 500 0.6× 152 0.8× 39 0.2× 46 0.8× 14 0.4× 23 586
Hanan M. Refaat Egypt 14 590 0.8× 173 0.9× 19 0.1× 69 1.1× 30 0.8× 22 704
Beatrice Bechi United Kingdom 9 421 0.5× 248 1.3× 43 0.3× 72 1.2× 9 0.2× 11 637
Shingo Obika Japan 12 721 0.9× 211 1.1× 64 0.4× 40 0.7× 9 0.2× 16 842

Countries citing papers authored by Khalid B. Selim

Since Specialization
Citations

This map shows the geographic impact of Khalid B. Selim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid B. Selim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid B. Selim more than expected).

Fields of papers citing papers by Khalid B. Selim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid B. Selim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid B. Selim. The network helps show where Khalid B. Selim may publish in the future.

Co-authorship network of co-authors of Khalid B. Selim

This figure shows the co-authorship network connecting the top 25 collaborators of Khalid B. Selim. A scholar is included among the top collaborators of Khalid B. Selim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalid B. Selim. Khalid B. Selim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tawfik, Samar S., et al.. (2025). Design, Synthesis and Molecular Docking of New Thieno[2,3‑d]Pyrimidin‐4‐One Derivatives as Dual EGFR and FGFR Inhibitors. Drug Development Research. 86(1). e70061–e70061. 1 indexed citations
2.
3.
Tawfik, Samar S., et al.. (2024). Design, synthesis, and in vitro and in vivo biological evaluation of triazolopyrimidine hybrids as multitarget directed anticancer agents. RSC Advances. 14(48). 35239–35254. 2 indexed citations
4.
5.
El‐Sayed, Magda A.‐A., et al.. (2023). Synthesis, Antitumor Activities, and Molecular Modeling of 4-Anilinoquinazoline Derivatives as EGFR-TK Inhibitors. Pharmaceutical Chemistry Journal. 57(8). 1215–1229. 1 indexed citations
6.
7.
Selim, Khalid B., et al.. (2022). Insights into modulating the monastrol scaffold: Development of new pyrimidinones as Eg5 inhibitors with anticancer activity. Archiv der Pharmazie. 355(10). e2200029–e2200029. 2 indexed citations
8.
9.
Mostafa, Amany, et al.. (2020). Design, synthesis and molecular modeling of phenyl dihydropyridazinone derivatives as B-Raf inhibitors with anticancer activity. Bioorganic Chemistry. 103. 104148–104148. 17 indexed citations
10.
Abou‐Zeid, Laila, et al.. (2020). 1,2,3-Triazole-Chalcone hybrids: Synthesis, in vitro cytotoxic activity and mechanistic investigation of apoptosis induction in multiple myeloma RPMI-8226. European Journal of Medicinal Chemistry. 189. 112062–112062. 68 indexed citations
11.
Zeidan, Mohamed A., Amany Mostafa, Laila Abou‐Zeid, et al.. (2019). Design, synthesis and docking study of novel picolinamide derivatives as anticancer agents and VEGFR-2 inhibitors. European Journal of Medicinal Chemistry. 168. 315–329. 69 indexed citations
12.
Selim, Khalid B., Magda A.‐A. El‐Sayed, Yhiya Amen, et al.. (2019). Design, Synthesis and Anticancer Evaluation of New Substituted Thiophene-Quinoline Derivatives. Bioorganic & Medicinal Chemistry. 27(19). 115026–115026. 51 indexed citations
13.
Selim, Khalid B., et al.. (2019). Dihydrofolate reductase inhibition effect of 5-substituted pyrido[2,3-d]pyrimidines: Synthesis, antitumor activity and molecular modeling study. Bioorganic Chemistry. 90. 103076–103076. 31 indexed citations
14.
Mostafa, Amany & Khalid B. Selim. (2018). Synthesis and anticancer activity of new dihydropyrimidinone derivatives. European Journal of Medicinal Chemistry. 156. 304–315. 46 indexed citations
15.
Selim, Khalid B., et al.. (2018). Design, synthesis, and molecular modeling of heterocyclic bioisostere as potent PDE4 inhibitors. Archiv der Pharmazie. 351(3-4). e1700403–e1700403. 5 indexed citations
16.
Kitamura, Mitsuru, et al.. (2017). Total Synthesis of Eleuthoside A; Application of Rh-Catalyzed Intramolecular Cyclization of Diazonaphthoquinone. Synlett. 29(4). 457–462. 10 indexed citations
17.
Selim, Khalid B., Yasumasa Matsumoto, Ken‐ichi Yamada, & Kiyoshi Tomioka. (2009). Efficient Chiral N‐Heterocyclic Carbene/Copper(I)‐Catalyzed Asymmetric Allylic Arylation with Aryl Grignard Reagents. Angewandte Chemie International Edition. 48(46). 8733–8735. 129 indexed citations
18.
Selim, Khalid B., Yasumasa Matsumoto, Ken‐ichi Yamada, & Kiyoshi Tomioka. (2009). Efficient Chiral N‐Heterocyclic Carbene/Copper(I)‐Catalyzed Asymmetric Allylic Arylation with Aryl Grignard Reagents. Angewandte Chemie. 121(46). 8889–8891. 41 indexed citations
19.
Selim, Khalid B., Ken‐ichi Yamada, & Kiyoshi Tomioka. (2008). Copper-catalyzed asymmetric allylic substitution with aryl and ethyl Grignard reagents. Chemical Communications. 5140–5140. 36 indexed citations
20.
Selim, Khalid B., Takahiro Soeta, Ken‐ichi Yamada, & Kiyoshi Tomioka. (2007). Amidophosphane–Copper(I)‐Catalyzed Asymmetric Conjugate Addition of Dialkylzinc Reagents to Racemic 6‐Substituted Cyclohexenones to Form 2,5‐Di‐ and 2,2,5‐Trisubstituted Cyclohexanones. Chemistry - An Asian Journal. 3(2). 342–350. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bodo Scheiper Breakdown of academic impact, for papers by Sravani Sana Breakdown of academic impact, for papers by You‐Cai Xiao Breakdown of academic impact, for papers by Craig A. Zificsak Breakdown of academic impact, for papers by Daniel T. Cohen Breakdown of academic impact, for papers by Rajesh Gontla Breakdown of academic impact, for papers by Akash P. Sakla Breakdown of academic impact, for papers by Hanan M. Refaat Breakdown of academic impact, for papers by Beatrice Bechi Breakdown of academic impact, for papers by Shingo Obika
Rankless by CCL
2026